2023 | Outcomes of single-port robotic ureteral reconstruction using the da Vinci SP® system
| INVESTIGATIVE AND CLINICAL UROLOGY |
2023 | Phosphodiesterase-5 Inhibitor Use in Robot Assisted Radical Prostatectomy Patients Is Associated with Reduced Risk of Death: A Propensity Score Matched Analysis of 1,058 Patients
| WORLD JOURNAL OF MENS HEALTH |
2022 | Noninvasive studies may have potential to replace cystoscopy in non-muscle invasive bladder cancer follow-up
| SCIENTIFIC REPORTS |
2022 | Characteristics of BRCA2 Mutated Prostate Cancer at Presentation
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2022 | Clinical Implications for da Vinci SP Partial Nephrectomy in High-Complexity Tumors: Propensity Score-Matching Analysis | JOURNAL OF ENDOUROLOGY |
2022 | Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies
| BIOMEDICINES |
2022 | External validation of karyotype nomogram to predict karyotype abnormalities in oligospermic men | ANDROLOGIA |
2022 | Evaluation of the Surgical Margin Threshold for Avoiding Recurrence after Partial Nephrectomy in Patients with Renal Cell Carcinoma
| YONSEI MEDICAL JOURNAL |
2022 | Gene Expression Analysis of Aggressive Adult Xp11.2 Translocation Renal Cell Carcinoma at Clinical Stage T1N0M0 to Identify Potential Prognostic and Therapeutic Biomarkers
| BIOMEDICINES |
2022 | Systemic Injection of Oncolytic Vaccinia Virus Suppresses Primary Tumor Growth and Lung Metastasis in Metastatic Renal Cell Carcinoma by Remodeling Tumor Microenvironment
| BIOMEDICINES |
2021 | Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
| PROSTATE CANCER AND PROSTATIC DISEASES |
2021 | Comparison of intraoperative and short-term postoperative outcomes between robot-assisted laparoscopic multi-port pyeloplasty using the da Vinci Si system and single-port pyeloplasty using the da Vinci SP system in children
| INVESTIGATIVE AND CLINICAL UROLOGY |
2021 | Prognostic value of prostate volume in non-muscle invasive bladder cancer
| SCIENTIFIC REPORTS |
2021 | Effect of Dexmedetomidine on Biochemical Recurrence in Patients after Robot-Assisted Laparoscopic Radical Prostatectomy: A Retrospective Study
| JOURNAL OF PERSONALIZED MEDICINE |
2021 | Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
| SCIENTIFIC REPORTS |
2021 | The Prognosis and Oncological Predictor of Urachal Carcinoma of the Bladder: A Large Scale Multicenter Cohort Study Analyzed 203 Patients With Long Term Follow-Up | FRONTIERS IN ONCOLOGY |
2021 | The DEAD/DEAH Box Helicase, DDX11, Is Essential for the Survival of Advanced Clear Cell Renal Cell Carcinoma and Is a Determinant of PARP Inhibitor Sensitivity
| CANCERS |
2021 | Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases | ANNALS OF SURGICAL ONCOLOGY |
2021 | Development of a highly pulmonary metastatic orthotopic renal cell carcinoma murine model
| BIOLOGY OPEN |
2021 | Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial
| CANCER & METABOLISM |
2020 | External validation of the post-varicocele repair semen analysis nomogram to predict total motile sperm count: A multicenter study | ANDROLOGIA |
2020 | Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
| DIAGNOSTICS |
2020 | Muscle Characteristics Obtained Using Computed Tomography as Prognosticators in Patients with Castration-Resistant Prostate Cancer
| CANCERS |
2020 | Prediction of High-Grade Clear Cell Renal Cell Carcinoma Based on Plasma mRNA Profiles in Patients With Localized Pathologic T1N0M0 Stage Disease
| CANCERS |
2020 | Association Between Prostate Cancer and 25-Hydroxyvitamin D2 Levels: National Health and Nutrition Examination Survey 2007−2008 Results
| Korean Journal of Urological Oncology (대한비뇨기종양학술지) |
2020 | True Single-Site Partial Nephrectomy Using the SP Surgical System: Feasibility, Comparison with the Xi Single-Site Platform, and Step-By-Step Procedure Guide | JOURNAL OF ENDOUROLOGY |
2020 | Comparison of Biochemical Recurrence After Robot-assisted Laparoscopic Radical Prostatectomy with Volatile and Total Intravenous Anesthesia
| INTERNATIONAL JOURNAL OF MEDICAL SCIENCES |
2020 | Urethral realignment with maximal urethral length and bladder neck preservation in robot-assisted radical prostatectomy: Urinary continence recovery
| PLOS ONE |
2020 | Gene Expression Analysis of Aggressive Clinical T1 Stage Clear Cell Renal Cell Carcinoma for Identifying Potential Diagnostic and Prognostic Biomarkers
| CANCERS |
2020 | Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2019 | Robot-assisted laparoscopic single-port pyeloplasty using the da Vinci SP® system: initial experience with a pediatric patient | JOURNAL OF PEDIATRIC UROLOGY |
2019 | The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer | PROSTATE |
2019 | Pure single-site robot-assisted pyeloplasty with the da Vinci SP surgical system: Initial experience
| INVESTIGATIVE AND CLINICAL UROLOGY |
2019 | Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion
| YONSEI MEDICAL JOURNAL |
2019 | Outcomes of pathologically localized high-grade prostate cancer treated with radical prostatectomy
| MEDICINE |
2019 | Is the extirpative surgery for primary tumor helpful for the patients with metastatic urothelial cancer at the time of diagnosis?
| MEDICINE |
2019 | Predictive Factors and Oncologic Outcome of Downgrade to Pathologic Gleason Score 6⁻7 after Radical Prostatectomy in Patients with Biopsy Gleason Score 8⁻10
| JOURNAL OF CLINICAL MEDICINE |
2019 | Clinical Significance of Multiparametric Magnetic Resonance Imaging as a Preoperative Predictor of Oncologic Outcome in Very Low-Risk Prostate Cancer
| JOURNAL OF CLINICAL MEDICINE |
2019 | Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers | COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL |
2019 | Preoperative controlling nutritional status (CONUT) score as a novel immune-nutritional predictor of survival in non-metastatic clear cell renal cell carcinoma of ≤ 7 cm on preoperative imaging | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2019 | Effect of prostate gland weight on the surgical and oncological outcomes of extraperitoneal robot-assisted radical prostatectomy
| BMC UROLOGY |
2018 | Clinical significance of multiparametric MRI and PSA density as predictors of residual tumor (pT0) following radical prostatectomy for T1a-T1b (incidental) prostate cancer
| PLOS ONE |
2018 | Predictive value of preoperative monocyte-lymphocyte ratio among patients with localized clear renal cell carcinoma of ≤7 cm on preoperative imaging
| MEDICINE |
2018 | Clinical significance and predictors of oncologic outcome after radical prostatectomy for invisible prostate cancer on multiparametric MRI
| BMC CANCER |
2018 | Management of postoperative ileus after robot-assisted laparoscopic prostatectomy.
| MEDICINE |
2018 | Efficacy and Safety of Robotic Procedures Performed Using the da Vinci Robotic Surgical System at a Single Institute in Korea: Experience with 10000 Cases
| YONSEI MEDICAL JOURNAL |
2018 | Impact of Early Salvage Androgen Deprivation Therapy in Localized Prostate Cancer after Radical Prostatectomy: A Propensity Score Matched Analysis
| YONSEI MEDICAL JOURNAL |
2018 | Age-adjusted Charlson Comorbidity Index as a prognostic factor for radical prostatectomy outcomes of very high-risk prostate cancer patients
| PLOS ONE |
2018 | Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer
| BMC CANCER |
2018 | Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases? | BJU INTERNATIONAL |